DAVITA INC. Business Combination, Contingent Consideration, Liability
DAVITA INC. (DVA) had Business Combination, Contingent Consideration, Liability of $42.38 million as of 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2021-02-12
- 2020-12-31: Business Combination, Contingent Consideration, Liability $42.38M.
- 2019-12-31: Business Combination, Contingent Consideration, Liability $33.89M.
- 2018-12-31: Business Combination, Contingent Consideration, Liability $11.21M.
- 2018-09-30: Business Combination, Contingent Consideration, Liability $7.23M.
| Period end | Business Combination, Contingent Consideration, Liability | Business Combination, Contingent Consideration, Liability as first filed |
|---|---|---|
| 2020-12-31 | $42.38M 10-K · filed 2021-02-12 | |
| 2019-12-31 | $33.89M 10-K · filed 2020-02-21 | |
| 2018-12-31 | $11.21M 10-K · filed 2019-02-22 | |
| 2018-09-30 | $7.23M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $7.49M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $6.56M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $6.39M 10-Q · filed 2018-11-07 | $11.47K 10-K · filed 2018-02-23 |
| 2017-09-30 | $8.96M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $11.67M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $8.56M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $9.98M 10-Q · filed 2017-11-07 | $7.22M 10-K · filed 2017-02-24 |
| 2015-12-31 | $29.05M 10-K · filed 2017-02-24 | |
| 2014-12-31 | $15.61M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $6.58M 10-K · filed 2015-02-26 | |
| 2012-12-31 | $142.24M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |